{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T10:55:38Z","timestamp":1766400938818},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00393-022-01232-2","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T18:15:21Z","timestamp":1657131321000},"page":"501-506","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Colchicine linked with risk reduction for myocardial infarction in gout patients: systematic review and meta-analysis"],"prefix":"10.1007","volume":"81","author":[{"given":"Huipeng","family":"Wan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linhong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruihai","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaochen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"issue":"8","key":"1232_CR1","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1136\/annrheumdis-2016-210275","volume":"76","author":"O Schieir","year":"2017","unstructured":"Schieir\u00a0O, Tosevski\u00a0C, Glazier\u00a0R, Hogg-Johnson\u00a0S, Badley\u00a0EJARD (2017) Incident myocardial infarction associated with major types of arthritis in the general population: a\u00a0systematic review and meta-analysis. Ann Rheum Dis 76(8):1396\u20131404","journal-title":"Ann Rheum Dis"},{"key":"1232_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12872-017-0513-6","volume":"17","author":"JA Singh","year":"2017","unstructured":"Singh\u00a0JA, Ramachandaran\u00a0R, Yu\u00a0SH, Curtis\u00a0JR (2017) Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes. BMC Cardiovasc Disord 17:76. https:\/\/doi.org\/10.1186\/s12872-017-0513-6","journal-title":"BMC Cardiovasc Disord"},{"key":"1232_CR3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jbspin.2018.06.011","volume":"86","author":"C Liang","year":"2018","unstructured":"Liang\u00a0C, Islam\u00a0M, Poly\u00a0T, Hsuan-ChiaYang\u00a0N, Jack\u00a0LY (2018) Association between gout and cardiovascular disease risk: a\u00a0nation-wide case-control study. Joint Bone Spine 86:389\u2013391. https:\/\/doi.org\/10.1016\/j.jbspin.2018.06.011","journal-title":"Joint Bone Spine"},{"issue":"4","key":"1232_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.maturitas.2014.05.001","volume":"78","author":"PC Robinson","year":"2014","unstructured":"Robinson\u00a0PC, Horsburgh\u00a0S (2014) Gout: Joints and beyond, epidemiology, clinical features, treatment and co-morbidities. Maturitas 78(4):245\u2013251","journal-title":"Maturitas"},{"key":"1232_CR5","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1161\/circulationaha.118.033992","volume":"138","author":"M Zhang","year":"2018","unstructured":"Zhang\u00a0M, Solomon\u00a0D, Desai\u00a0R et al (2018) Assessment of cardiovascular risk in older patients with gout initiating Febuxostat versus allopurinol: a\u00a0population-based cohort study. Circulation 138:1116\u20131126. https:\/\/doi.org\/10.1161\/circulationaha.118.033992","journal-title":"Circulation"},{"key":"1232_CR6","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1002\/art.40583","volume":"70","author":"H Choi","year":"2018","unstructured":"Choi\u00a0H, Neogi\u00a0T, Stamp\u00a0L, Dalbeth\u00a0N, Terkeltaub\u00a0R (2018) Implications of the cardiovascular safety of febuxostat and allopurinol in patients with gout and cardiovascular morbidities (CARES) trial and associated FDA public safety alert. Arthritis Rheumatol 70:1702\u20131709. https:\/\/doi.org\/10.1002\/art.40583","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"1232_CR7","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/rheumatology\/kex065","volume":"56","author":"T Zhang","year":"2017","unstructured":"Zhang\u00a0T, Pope\u00a0J (2017) Cardiovascular effects of urate-lowering therapies in patients with chronic gout: a\u00a0systematic review and meta-analysis. Rheumatology 56(7):1144\u20131153","journal-title":"Rheumatology"},{"key":"1232_CR8","unstructured":"Igel T, Romero AG, Pike V et al (2017) Initiating colchicine and Urate-lowering therapy reduces baseline inflammation, and improves vascular endothelial but not smooth muscle function in gout subjects: resistance to endothelial improvement among patients with cardiovascular Comorbidities. Arthritis Rheumatol 69. https:\/\/acrabstracts.org\/abstract\/initiating-colchicine-and-urate-lowering-therapy-reduces-baseline-inflammation-and-improves-vascular-endothelial-but-not-smooth-muscle-function-in-gout-subjects-resistance-to-endothelial-improvement\/"},{"issue":"1","key":"1232_CR9","doi-asserted-by":"publisher","first-page":"i4","DOI":"10.1093\/rheumatology\/kex453","volume":"57","author":"A Slobodnick","year":"2018","unstructured":"Slobodnick\u00a0A, Shah\u00a0B, Krasnokutsky\u00a0S, Pillinger\u00a0MH (2018) Update on colchicine, 2017. Rheumatology 57(1):i4\u2013i11","journal-title":"Rheumatology"},{"issue":"2","key":"1232_CR10","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/bjd.15896","volume":"178","author":"B Dasgeb","year":"2018","unstructured":"Dasgeb\u00a0B, Kornreich\u00a0D, McGuinn\u00a0K, Okon\u00a0L, Brownell\u00a0I, Sackett\u00a0DL (2018) Colchicine: an ancient drug with novel applications. Br J Dermatology 178(2):350\u2013356","journal-title":"Br J Dermatology"},{"issue":"7","key":"1232_CR11","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.3899\/jrheum.111533","volume":"39","author":"DB Crittenden","year":"2012","unstructured":"Crittenden\u00a0DB, Lehmann\u00a0RA, Schneck\u00a0L et\u00a0al (2012) Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout. J\u00a0Rheumatol 39(7):1458\u20131464","journal-title":"J Rheumatol"},{"issue":"9","key":"1232_CR12","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1136\/annrheumdis-2015-207984","volume":"75","author":"DH Solomon","year":"2016","unstructured":"Solomon\u00a0DH, Liu\u00a0CC, Kuo\u00a0IH, Zak\u00a0A, Kim\u00a0SC (2016) Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with medicare claims. Ann Rheum Dis 75(9):1674\u20131679","journal-title":"Ann Rheum Dis"},{"key":"1232_CR13","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1136\/annrheumdis-2014-eular.1664","volume":"73","author":"M Dubreuil","year":"2014","unstructured":"Dubreuil\u00a0M, Peloquin\u00a0C, Zhang\u00a0Y, Neogi\u00a0T, Choi\u00a0HK (2014) Colchicine use and risk of myocardial infarction among gout patients\u2014a\u00a0general population study. Ann Rheum Dis 73:1157\u20131158. https:\/\/doi.org\/10.1136\/annrheumdis-2014-eular.1664","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"1232_CR14","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1016\/j.cjca.2020.05.026","volume":"36","author":"B Shah","year":"2020","unstructured":"Shah\u00a0B, Toprover\u00a0M, Crittenden\u00a0DB et\u00a0al (2020) Colchicine use and incident coronary artery disease in male patients with gout. Can J Cardiol 36(11):1722\u20131728","journal-title":"Can J Cardiol"},{"issue":"12","key":"1232_CR15","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1002\/acr.22067","volume":"65","author":"SC Kim","year":"2013","unstructured":"Kim\u00a0SC et al (2013) Clinical and health care use characteristics of patients newly starting allopurinol, febuxostat, and colchicine for the treatment of gout. Arth Care Res 65(12):2008\u20132014","journal-title":"Arth Care Res"},{"issue":"12","key":"1232_CR16","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1002\/acr.22067","volume":"65","author":"SC Kim","year":"2013","unstructured":"Kim\u00a0SC, Schmidt\u00a0BMW, Franklin\u00a0JM, Liu\u00a0J, Solomon\u00a0DH, Schneeweiss\u00a0S (2013) Clinical and health care use characteristics of patients newly starting allopurinol, febuxostat, and colchicine for the treatment of gout. Arthritis Care Res 65(12):2008\u20132014","journal-title":"Arthritis Care Res"},{"key":"1232_CR17","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati\u00a0A, Altman\u00a0D, Tetzlaff\u00a0J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700","journal-title":"BMJ"},{"issue":"3","key":"1232_CR18","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/art.1780200320","volume":"20","author":"SL Wallace","year":"2014","unstructured":"Wallace\u00a0SL, Robinson\u00a0H, Masi\u00a0AT, Decker\u00a0JL, McCarty\u00a0DJ, Y\u00fc\u00a0TF (2014) Preliminary criteria for the classification of the acute arthritis of primary gout. Arth Rheuma 20(3):895\u2013900","journal-title":"Arth Rheuma"},{"issue":"9","key":"1232_CR19","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang\u00a0A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603\u2013605","journal-title":"Eur J Epidemiol"},{"key":"1232_CR20","unstructured":"Moola SMZ, Tufanaru C et\u00a0al (2017) Systematic reviews of etiology and risk. In: JBI Manual for Evidence Synthesis"},{"key":"1232_CR21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jclinepi.2020.08.019","volume":"142","author":"SA Doi","year":"2020","unstructured":"Doi\u00a0SA, Furuya-Kanamori\u00a0L, Xu\u00a0C, Lin\u00a0L, Chivese\u00a0T, Thalib\u00a0L (2020) Questionable utility of the relative risk in clinical research: a\u00a0call for change to practice. J\u00a0Clin Epidemiol 142:271\u2013279. https:\/\/doi.org\/10.1016\/j.jclinepi.2020.08.019","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"20","key":"1232_CR22","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1002\/sim.2380","volume":"25","author":"RM Harbord","year":"2006","unstructured":"Harbord\u00a0RM, Egger\u00a0M, Sterne\u00a0JAC (2006) A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Statist Med 25(20):3443\u20133457","journal-title":"Statist Med"},{"key":"1232_CR23","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1002\/art.38460","volume":"66","author":"DB Crittenden","year":"2014","unstructured":"Crittenden\u00a0DB, Kimmel\u00a0JN, Pike\u00a0VC et\u00a0al (2014) Colchicine and the risk of acute cardiovascular (CV) events among gout patients: the New York department of veterans affairs retrospective cohort study. Arthritis Rheumatol 66:S65\u2013S66","journal-title":"Arthritis Rheumatol"},{"issue":"19","key":"1232_CR24","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","volume":"383","author":"SM Nidorf","year":"2020","unstructured":"Nidorf\u00a0SM, Fiolet\u00a0ATL, Mosterd\u00a0A et\u00a0al (2020) Colchicine in patients with chronic coronary disease. N\u00a0Engl J Med 383(19):1838\u20131847","journal-title":"N Engl J Med"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-022-01232-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-022-01232-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-022-01232-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T13:31:24Z","timestamp":1659101484000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-022-01232-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1232"],"URL":"https:\/\/doi.org\/10.1007\/s00393-022-01232-2","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,6]]},"assertion":[{"value":"23 May 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.\u00a0Wan, L.\u00a0Zeng, R.\u00a0Xiao, X.\u00a0Tang, Y.\u00a0Shu and S.\u00a0Shen declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}